Phase 1b trial of pembrolizumab monotherapy for relapsed/refractory multiple myeloma: KEYNOTE-013

Vincent Ribrag, David E Avigan, Damian J Green, Trisha Wise-Draper, Juan G Posada, Ravi Vij, Ying Zhu, Mohammed Z H Farooqui, Patricia Marinello, David S Siegel, Vincent Ribrag, David E Avigan, Damian J Green, Trisha Wise-Draper, Juan G Posada, Ravi Vij, Ying Zhu, Mohammed Z H Farooqui, Patricia Marinello, David S Siegel

No abstract available

Keywords: PD-1 (PDCD1); multiple myeloma; pembrolizumab.